학술논문
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Document Type
Article
Author
Shurtleff, V.W.; Layton, M.E.; Perkins, J.J.; Schreier, J.D.; Wang, Y.; Adam, G.C.; Bahnck-Teets, C.M.; Boyce, C.W.; Burlein, C.; Cabalu, T.D.; Campbell, B.T.; Carroll, S.S.; de Lera Ruiz, M.; Fay, J.F.; Goh, S.L.; Hartingh, T.J.; Hurzy, D.M.; Kelly, M.J.; Klein, D.J.; Krishnamurthy, H.; Kudalkar, S.; McKenna, P.M.; Murray, E.M.; Nahas, D.; Nawrat, C.C.; Roecker, A.J.; Shipe, W.D.; Taggart, R.V.; Olsen, D.B.; Howe, J.A.; McCauley, J.A.; Parish, C.A.; Bahmanjah, S.; Chang, W.; Fox, N.G.; Mayhood, T.W.; Su, J.; Truong, Q.; Zhou, X.; Alvarez, N.; Dolgov, E.; Park, S.; Sharma, V.; Perlin, D.S.; Klingler, F.-M.; Qian, D.; Wu, Y.; Zhuang, N.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 14 March 2024, 67(5):3935-3958)
Subject
Language
English
ISSN
15204804
00222623
00222623